Institutional investors purchased a net $1.8 million shares of ATRS during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 32.27% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLENNIUM MANAGEMENT LLC Bought 1.5 Million shares of Antares Pharma Inc
RUBRIC CAPITAL MANAGEMENT LP Bought 1.2 Million shares of Antares Pharma Inc
MORGAN STANLEY & CO. LLC Bought 651.8 Thousand shares of Antares Pharma Inc